
Special Report: The 2024 Lab Enforcement Landscape
Lab leaders should be wary of telemedicine arrangements, certain marketing firms, and unnecessary PGx and CGx testing
Lab leaders should be wary of telemedicine arrangements, certain marketing firms, and unnecessary PGx and CGx testing
Know where labs may fall foul of compliance requirements—and discover the actions your lab can take to mitigate the risk of noncompliance
When structuring business arrangements, addressing six key risk areas can help laboratories avoid major compliance issues.
An overview of likely lab audit targets for the coming year, and how laboratories can ensure they’re prepared.
Recent advisory opinion offers insight on how healthcare providers may want to structure arrangements involving online directories.